Clinical Trial Update: Impact of Erythropoietin Treatment Versus Placebo on Quality-of-life in Patients With Advanced Prostate Cancer. [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing erythropoietin to placebo to assess quality of life in men with advanced prostate cancer has completed. The update lists Janssen-Ortho…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Erythropoietin (erythropoietin)

Snippet

Sponsor: Janssen-Ortho Inc., Canada | Conditions: Prostate, Carcinoma | Phase 3 | Status: COMPLETED